The increase in mortality associated with reduced screening coverage suggests low adherence to early detection and possible inefficiencies in local public health policies.
Abstract
Introduction: Breast cancer is the leading cause of cancer-related death among Brazilian women and the most common cancer in this population. Early diagnosis is crucial, offering up to a 95% survival rate. The Instituto Nacional de Câncer (INCA) estimated approximately 73,610 new cases in Brazil for 2025. The state of Roraima presents one of the highest mortality rates in the country, with 17.38 deaths per 100,000 women in 2023. Screening mammography for women aged 50–69 years (extended up to 74 years according to recent public health guidelines) is recommended every two years and remains the most effective strategy to reduce mortality, enabling early detection in asymptomatic women.
Objective: To evaluate screening mammography coverage and breast cancer mortality from 2020 to 2024, and to assess the effectiveness of public health policies aimed at early detection in the state of Roraima.
Methods: A descriptive study using secondary data from the Outpatient Information System of the Brazilian Unified Health System (SIA/SUS) and INCA. Data on screening mammography (women aged 50–69 years) and mortality were analyzed. Coverage rates were calculated as the ratio between approved exams and the target population defined by the Brazilian Institute of Geography and Statistics (IBGE).
Results: Breast cancer mortality rates in Roraima showed a significant upward trend, increasing from 7.92 per 100,000 women in 2020 to 15.58 per 100,000 in 2024 (≈97% increase). Screening mammography coverage declined over the same period, with 2,326 exams performed in 2020 to 1,391 in 2024. A total of 8,761 exams were performed during the study period.
Conclusion: The increase in mortality associated with reduced screening coverage suggests low adherence to early detection and possible inefficiencies in local public health policies. Strengthening screening strategies and expanding access to early diagnosis are essential to improve women’s health outcomes in Roraima.
Abstract Background Breast cancer is the leading cause of cancer death among women globally. In Italy, approximately 55,900 new cases and 15,500 deaths were recorded in 2022–2023. In Sicily, mammographic screening (MS) adherence persistently falls below national and European targets, creating a health equity gap. In de...
M. LaBella, S. Scondotto, W. P. Addario et al.· European Journal of Public H...· 0 citations
Introduction: Malignant breast neoplasm is a major public health challenge, ranking as the most frequently diagnosed cancer among women in Brazil, excluding non-melanoma skin cancer. It also remains the leading cause of female cancer-related mortality. Screening is vital for early diagnosis and is predominantly perform...
Mirella Laranjeira Nunes, Luan Fernandes Lins, Ana Carolina Ferraz Pascoal et al.· Mastology· 0 citations
Significant shifts in breast cancer mortality rates in Brazil are demonstrated, with increases among young women since 2021/2022 in some Brazilian regions, underscore the urgent need for targeted public policies to improve early diagnosis and reverse the current upward trends.
Luiz Henrique Alves Costa, Hellen Rocha da Luz, I. M. Calassa et al.· Mastology· 0 citations
Breast cancer remains the most common cancer among women worldwide and a major cause of cancer-related mortality, particularly in low- and middle-income countries (LMICs), where barriers to early detection persist. Mammography screening plays a critical role in reducing breast cancer mortality through early diagnos...
Martina de Sá, Arthur Simas Heisser, Juliana Rosset et al.· JCO Global Oncology· 0 citations
Mammographic screening in women aged 40–49 years was associated with a significant decrease in breast cancer mortality, and the findings suggest potential benefits and support consideration of screening expansion to this population.
Nícolas Marques Barros, Igor Diniz Alves, Walter Johnatha dos Santos Pereira et al.· Mastology· 0 citations
Introduction: Breast cancer screening through mammography is recommended for women aged 50–69 years and plays a crucial role in early detection and mortality reduction. However, disparities in access and coverage persist across all Brazilian regions. This study aimed to evaluate mammography screening trends in women ag...
Anna Laura de Paula Rego, Stefany Cristina de Jesus Alves, Maria Carolina Martins da Conceição et al.· Mastology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.